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INTRODUCTION
Recognizing and treating shock is essential to saving the lives of injured or ill war fighters. Emerging data suggests that early aggressive resuscitation of critically ill patients may limit or reverse tissue hypoxia progressing to organ failure. 1 
HYPOTHESIS
It is feasible for air medical providers to use serum lactate and tissue oximetric monitoring (StO 2 ) devices in early shock contemporaneously with their care.
BODY

IRB Approval
In order to investigate the use of lactate and tissue oximetry for the early detection and treatment of circulatory shock, we conducted a feasibility study of the use of these devices in the air medical environment. Institutional Review Board (IRB) approval was obtained for a study utilizing lactate and StO2 in healthy volunteers. Following the healthy volunteer study, we sought IRB approval for an observational study of trauma patients flown to UPMC Presbyterian hospital. This study will be conducted using waiver of informed consent and the non-invasive monitoring technologies previously tested in the human volunteer study. We will conduct an interventional study directing patient care with non-invasive monitoring under the exception from informed consent rules. This IRB approval will be sought during the observational trial and will require public disclosure and community consultation.
Community consultation for this process will entail meetings with community representatives and stakeholders. Public meetings to address questions and concerns will be held in the county seats of areas serviced by our helicopters. Mixed media advertisements will be used to notify the public of these meetings. Bracelets will be provided for those who wish to opt out of the study. Concomitant with these efforts, the protocol will be submitted for second level review by the Air Force Surgeon General's Office (SGRC office). 
Clinical Protocols
Training of Flight Crews
Testing of Lactate and StO 2 Meters in Flight
The point of care lactate meter and tissue oximeter was evaluated in our laboratory on healthy volunteers to determine the effects of field conditions and the prehospital environment. We subjected fifteen healthy volunteers to extremes of temperature and regional ischemia. This testing demonstrated that data could be obtained despite complete and partial limb ischemia and exposure to temperatures of 4 and 40 ºC. Differences in StO 2 and lactate from baseline was tested by repeated measures ANOVA.
We tested the effects of regional ischemia using partial and total forearm occlusion tests.
The means and SD are in the table below. There was a significant difference over time for the occlusion test (F 10,18 =61.7, p < 0.001) indicating that StO 2 decreases with decreased perfusion to the thenar tissue and rapidly recovers with reperfusion. There was no difference between partial occlusion and total occlusion (Table 1, Figure 1 ). 
Figure 1. Graphic Depiction of the Results From the Occlusion and Partial Occlusion Test
We also evaluated the effect of temperature changes on serum lactate and tissue saturation using either immersion of the forearm in a 4-ºC water bath or exposure to a heating pad (tables 2 and 3 meters were also evaluated by the aviation department with the help of materials from
Hutchinson Technologies, the manufacturer of the device, and were tested during nonpatient flights. We conducted safety interference testing in all aircraft models utilized by the aviation department of STAT MedEvac (see appendix). The devices have only been used on healthy subjects during maintenance flights and non-patient legs. Crew compliance with device calibration has been 100% and no problems have been reported during their limited use. We surveyed flight crewmembers regarding their perceptions of the testing devices using a five point Likert scale.
Flight-testing on healthy volunteers was originally allotted six weeks to accrue 20 subjects. Enrollment has taken longer then anticipated due to the unpredictable nature of flights and completion of this phase of the project will likely take 10 weeks.
Flight Crew Training Program
A program of instruction on how to conduct the healthy volunteer experiments and how to interpret the data from the StO 2 occlusion test was instituted at MedEvac 1 and 4 the bases directly involved in the healthy subject study. Instruction sessions were conducted by my research assistant or myself and involved a review of the consent document and an introduction to the study protocol. Flight crewmembers that volunteered as subjects were
given an instructions on how to record data from the experiments.
Between and Within-Trial Reliability of Lactate and StO 2 in Flight
Our goal for the feasibility study is to show (1) These data demonstrate that flight crewmembers can reliably obtain serum lactate values in flight. There is variability in the measurements due to technician skills, flight conditions, and day-to-day lactate differences for an individual. However, variations in lactate measurements were within normal values for healthy volunteers and had a small range of standard deviations indicating that there was reasonable inter-trial reliability (Table 4 ). The range of standard deviations across time points was very small from 0.38 to 0.54, indicating that the individual technician accounts for over half the variability (52%) in lactates sampled during flight. We also ran a mixed model with fixed time effects and random technician effects to partition the variability in the lactate measures and to estimate the correlation of measurements within technicians. We did not observe differences related to aircraft type or operational conditions. Overall, the observed standard deviations were acceptable and would not be likely to yield a false signal leading to inappropriate patient management. 
StO 2 Analysis
Analysis for the StO 2 outcomes were also evaluated using descriptive statistics including means, standard deviations, and confidence intervals for each time point across technicians (Table 5) . StO 2 measurements in and of themselves are not better able to predict shock states than existing vital signs. 4 Use of the occlusion test increases the utility of StO 2 measurement by allowing the determination of tissue metabolic needs during the period of ischemia described as T1 (time from occlusion of forearm blood vessels to limb ischemia) and the time of recovery T2 (time from release of the BP cuff until the StO 2 level has returned to the subjects baseline) which indicates the state of perfusion of the forearm. If the patient is in compensated shock and regional perfusion is compromised, the slope of T2 will be decreased. 4 The distributions for the T1 and T2 (Figures 2 and 3) . Under the study protocol data on the patient's tissue oxygen saturation will be collected but will not alter treatment during flight. This is a waiver of informed consent study as trauma patients requiring air medical transport are not likely to be capable of informed consent. The University of Pittsburgh recently approved this study as it represents minimal risk to the patient (non invasive monitoring) and may provide direct benefit thought better patient monitoring and increased quality assurance. Data analysis will involve correlation between StO 2 values and patient outcomes including multi system organ failure (MSOF), need for surgery, need for blood products (first 24 hours), need for admission to the ICU, length of stay, number of ventilator days, total fluid requirement (first 24 hours), need for pressors and mortality. Our current assumption is that values less than 70% are correlated with the adverse outcomes noted above and indicate the need for resuscitation despite normal vital signs. The observational study will not be conducted under this contract.
Training of a Second Research Assistant
A second research assistant was not trained, as second level approval was not received from the Air Force.
Problems Associated with this Study
Waiver of informed consent process for the observational study The observational study uses a minimal risk waiver of informed consent mechanism that has been approved by the University of Pittsburgh. The University IRB considers it minimal risk because it involves only prospective recording of data without changes in patient care protocols during transport. A requirement of the SGRC waiver of informed consent mechanism is that it provides direct benefit to the patient. In this case the direct benefit is the more vigilant monitoring of the patient including the ability to monitor the progress of resuscitation for patients who will receive fluid and blood products based on vital sign parameters. The contract was completed prior to obtaining a waiver of informed consent.
Correlation of StO2 and Serum Lactate with Adverse Outcomes
The outcome of the observational study that will justify continuing the interventional study would be the ability of lactate and StO 2 to predict an elevated MODS score (>6). This is a surrogate marker of clinically significant circulatory shock. If the StO 2 and lactate cannot identify circulatory shock then there is no need to complete the intervention. In regard to the correlation of shock with StO 2 and lactate being insufficient to justify the intervention, lactate is a product of hypoperfused tissue. It is a very sensitive indicator of shock but not specific. That is why it must be paired with StO 2 . StO 2 is a measure of regional hypoperfusion and existing data describe decreased StO 2 and increased recovery of StO 2 following the occlusion test as a consequence of shock. Shock is defined as the hypo perfusion of tissue. Eastern Association of Surgery of Trauma (EAST) has suggested these measures as guidelines for the endpoints of resuscitation. 5 We hope to continue this line of investigation and demonstrate that the StO 2 occlusion test is sensitive for detecting early or compensated shock.
Determination of the optimal cutoff for StO2
Current data using StO 2 for the monitoring of patients suffering traumatic shock suggests increased organ dysfunction with StO 2 values less than 65% correlate with increased incidence of organ dysfunction. 6 StO 2 values less than 70% are indicative the need for transfusion of blood products and longer hospital length of stay. 7 We hypothesize that StO 2 levels less than 70% may represent an additional endpoint for resuscitation. In order to further investigate that hypothesis the observational trial will involve the recording StO 2 levels on all trauma patients taken to UPMC Presbyterian hospital. These patients would be enrolled under waiver of informed consent in this minimal risk trial. No changes will be made in their treatment during the transport and patient records will be examined to define associations between StO 2 levels in this prehospital population and
Multi system organ failure as well the need for blood products, fluids, ICU admission, length of stay, surgery, intubation and mechanical ventilation, and mortality.
Potential for over resuscitation The risks and hazards of unnecessary resuscitation with normal saline include pulmonary edema, dilution of coagulation factors, abdominal compartment syndrome, and dislodging clots in uncontrolled hemorrhage. Pulmonary edema may occur inpatients with unrecognized kidney failure or congestive heart failure. This could result in a decreased ability to oxygenate the patient possibly requiring endotracheal intubation.
Monitoring the patients breathing and oxygen saturations will minimize the risk of volume overload. Physiological monitoring in this patient population is routine and includes SPO 2 , EtCO 2 , ECG, and non-invasive blood pressure. Large volume resuscitation with crystalloid will dilute clotting factors potentially increasing the severity of hemorrhage. There is a theoretical risk of dislodging blood clots in penetrating or vascular injuries worsening ongoing bleeding and requiring additional resuscitation.
Studies involving the administration of aggressive early resuscitation have identified these issues in penetrating trauma. Investigators have suggested that resuscitating to a given blood pressure is fraught with complication and that other endpoints of resuscitation should be studied including lactate and measures of tissue oxygenation. 8, 9 Capillary lactate: The point of care lactate device used in this study is marketed as being able to receive samples from capillary, venous or arterial sources. Arterial lactates are the gold standard but recent publications have indicated that venous lactate is equivalent. 10 Venous samples are the preferred means of obtaining lactate for this study as the patients are required to have venous access making the test essentially non invasive. We tested capillary lactate as an alternative in both the laboratory and in flight. It was noted that lactate values are falsely elevated if the alcohol used to cleanse the finger was not completely evaporated or if the finger required milking to extract a sample. Under ideal circumstances in the lab these risks could be minimized but in the field and air medical environments capillary lactate is not reliable. As a corrective action, only venous samples are to be used in future studies. 
Waste for venous samples
Lactate device failures
The point of care lactate devices have had seven failures during the past four months now totaling more than 500 uses by >150 crew members. All but one has been identified as operator error. The crews were retrained on the appropriate use of the device and notices sent to all employees were sent out when possible systems issues were identified.
Key Research Accomplishments
-IRB approval for the laboratory phase of the study obtained These preliminary studies demonstrate the feasibility of using lactate and tissue oximetry in the austere conditions of the air medical environment. In addition, we also show that nurses and paramedics can reliably obtain lactate and StO 2 values with minimal training and without the supervision provided in the hospital.
Further studies should demonstrate that prehospital tissue oximetric values below a given threshold correlate with adverse outcomes including multi system organ failure, need for blood products and increased hospital length of stay. This step is necessary because the current literature supports an association between StO 2 and adverse outcomes in trauma 
